Walleye Capital LLC Zai Lab LTD Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$24.32 - $43.03 $202,512 - $358,310	-8,327 Reduced 37.38%	13,949 $487,000
Q1 2025 May 14, 2025	BUY	$24.29 - $38.35 $530,445 - $837,487	21,838 Added 4985.84%	22,276 $805,000
Q4 2024 Feb 13, 2025	SELL	$24.61 - $33.18 $74,076 - $99,871	-3,010 Reduced 87.3%	438 $11,000
Q3 2024 Nov 14, 2024	SELL	$16.25 - $24.14 $306,621 - $455,497	-18,869 Reduced 84.55%	3,448 $83,000
Q2 2024 Aug 14, 2024	BUY	$13.72 - $21.55 $12,402 - $19,481	904 Added 4.22%	22,317 $386,000

Q1 2024 May 15, 2024	BUY	$15.95 - $26.8 $341,537 - $573,868	21,413 New	21,413 $343,000

154

32.7M

168K

222K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.13B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.